Complications in immunosuppressive therapy of liver transplant recipients

Salvatore Gruttadauria, Fabrizio Di Francesco, Duilio Pagano, Giovanni Vizzini, Davide Cintorino, Marco Spada, Fabio Tuzzolino, Bruno Gridelli

Research output: Contribution to journalArticle


Background: In liver transplantation (LT), modern immunosuppressive protocol is focused on early corticosteroid (CS) weaning. The aim of the study was to investigate all early transplant-related complications using Clavien grading system, in order to identify a significant relation in two homogenous groups of consecutive liver transplanted patients, only different for steroid avoidance in immunosuppressive regimen. Materials and Methods: One group was treated with a tacrolimus-based CS-free immunosuppressive protocol, the other one underwent tacrolimus plus low dose CS therapy. The preoperative continuous variables analyzed were age, gender, model for end-stage liver disease (MELD) score, and the pre-allocation score for predicting survival following liver transplantation (P-SOFT). Results: There were 39 patients in Group A (CS free) (37.9%), and 64 patients in Group B (CS on board) (62.1%). No statistically significant differences between the two groups were detected regarding the incidence and Clavien grade of complications (P = 0.116). No significant relation was revealed between Clavien rate of complications and tacrolimus-based CS-free immunosuppressive protocol, comparing the two subgroup of patient with P-SOFT score <6 and ≥ 6 (P = 0.193). This association was noted comparing the two subgroups on tacrolimus plus low dose CS regimen (P = 0.013). Conclusion: In this series, the use of CS in sick patient is associated with higher morbidity identified by the Clavien classification.

Original languageEnglish
JournalJournal of Surgical Research
Issue number1
Publication statusPublished - Jun 1 2011


  • complication
  • immunosuppression
  • liver transplantation
  • rejection

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Complications in immunosuppressive therapy of liver transplant recipients'. Together they form a unique fingerprint.

  • Cite this